Armonia Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.12 M
as on 11-12-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 7.80 Cr
as on 11-12-2024
- Revenue -94.77%
(FY 2022)
- Profit 12.72%
(FY 2022)
- Ebitda 9.14%
(FY 2022)
- Net Worth -31.79%
(FY 2022)
- Total Assets -28.10%
(FY 2022)
About Armonia Life Science
The Corporate was formerly known as Univision Insurance Services Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹7.80 Cr.
Abhijeet Kumar, Vedant Kulkarni, and Pundalik Kadam serve as directors at the Company.
- CIN/LLPIN
U24100MH2004PTC144428
- Company No.
144428
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2004
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Armonia Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijeet Kumar  | Director | 01-Nov-2017 | Current |
| Vedant Kulkarni | Director | 01-Sep-2021 | Current |
| Pundalik Kadam | Director | 25-Oct-2023 | Current |
Financial Performance of Armonia Life Science.
Armonia Life Science Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 94.77% decrease. The company also saw a substantial improvement in profitability, with a 12.72% increase in profit. The company's net worth observed a substantial decline by a decrease of 31.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Armonia Life Science?
In 2022, Armonia Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Harmony Lifescience Private LimitedActive 8 years 9 monthsAbhijeet Kumar, Vedant Kulkarni and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
New India Co-Op Bank Limited Creation Date: 15 Feb 2019 | ₹7.80 Cr | Open |
How Many Employees Work at Armonia Life Science?
Unlock and access historical data on people associated with Armonia Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Armonia Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Armonia Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
